Zacks4d agoneutral
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?ABT's Q1 beat was overshadowed by Exact Sciences dilution, legal risks and weak Diagnostics trends as shares hit a 52-week low.
Notícias
Apenas manchetes de alto sinal — eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
55last 24h
1680last 7d
312🟢 bullish (7d)
171🔴 bearish (7d)
136publishers
MarketBeat8d agoneutral
Tandem Diabetes Care Q1 Earnings Call HighlightsTandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel reimbursement, expands direct international operations and prepares several product
